Cargando…
Metastatic renal cell cancer treatments: An indirect comparison meta-analysis
BACKGROUND: Treatment for metastatic renal cell cancer (mRCC) has advanced dramatically with understanding of the pathogenesis of the disease. New treatment options may provide improved progression-free survival (PFS). We aimed to determine the relative effectiveness of new therapies in this field....
Autores principales: | Mills, Edward J, Rachlis, Beth, O'Regan, Chris, Thabane, Lehana, Perri, Dan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637892/ https://www.ncbi.nlm.nih.gov/pubmed/19173737 http://dx.doi.org/10.1186/1471-2407-9-34 |
Ejemplares similares
-
Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison
por: O'Regan, Christopher, et al.
Publicado: (2009) -
Estimating the Power of Indirect Comparisons: A Simulation Study
por: Mills, Edward J., et al.
Publicado: (2011) -
Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis
por: Cooper, Curtis L, et al.
Publicado: (2012) -
Modelling heterogeneity variances in multiple treatment comparison meta-analysis – Are informative priors the better solution?
por: Thorlund, Kristian, et al.
Publicado: (2013) -
Comparative Effects Between Direct Oral Anticoagulants for Acute Venous Thromboembolism: Indirect Comparison From Randomized Controlled Trials
por: Li, Guowei, et al.
Publicado: (2020)